VijithRoy
☆    

India,
2021-03-03 09:35
(1341 d 20:37 ago)

Posting: # 22239
Views: 3,088
 

 Confidence interval for PK and PD analysis [General Sta­tis­tics]

Hello everyone,

Why do we set 95% CI for PD data analysis and 90% CI for PK analysis.? Why not 90% CI for PD data analysis?

Please kindly clarify me and correct me if am wrong anywhere.


Edit: Category changed; see also this post #1[Helmut]

With Best Regards,
Vroy.
ElMaestro
★★★

Denmark,
2021-03-03 12:15
(1341 d 17:56 ago)

@ VijithRoy
Posting: # 22240
Views: 2,414
 

 Confidence interval for PK and PD analysis

Hello VijithRoy,

❝ Why do we set 95% CI for PD data analysis and 90% CI for PK analysis.? Why not 90% CI for PD data analysis?


can you please be much more specific?
There are lots of 90% CI's used in PD, so in order to get towards an answer for your question can you please give a lot more context including: Where do you submit the dossier, what drug is it, what is your endpoint, did you get sc.advice or do a controlled correspondence with the authority etc?

Pass or fail!
ElMaestro
VijithRoy
☆    

India,
2021-03-04 11:03
(1340 d 19:09 ago)

@ ElMaestro
Posting: # 22241
Views: 2,323
 

 Confidence interval for PK and PD analysis

❝ There are lots of 90% CI's used in PD, so in order to get towards an answer for your question can you please give a lot more context including: Where do you submit the dossier, what drug is it, what is your endpoint, did you get sc.advice or do a controlled correspondence with the authority etc?


Dear ElMaestro,

I was assuming that 95% CI uses for PD and 90% CI for PK analysis.
So setting up the CI depends upon our Statistical Modeling?


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

With Best Regards,
Vroy.
UA Flag
Activity
 Admin contact
23,280 posts in 4,889 threads, 1,655 registered users;
68 visitors (0 registered, 68 guests [including 12 identified bots]).
Forum time: 06:12 CET (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5